Compare Eli Lilly And Co (LLY) vs Open Text Corporation (OTEX) Price & Performance

Eli Lilly (LLY) trades at $1,223.97, down 0.62% on the day, maintaining strong bullish momentum with consecutive earnings beats and robust revenue growth. The stock shows technical strength above key support levels at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 102.44% ROE. Recent quarterly results exceeded expectations, with Q2 2026 revenue surging 48% to $23 billion driven by Mounjaro and Zepbound demand.

Outlook remains positive with analyst consensus targeting $1,380 and 73% buy ratings, though elevated valuations (P/E 40.8) and regulatory risks around weight-loss drug competition present headwinds. The company's pipeline advancement with retatrutide filing expected in 2027 provides medium-term growth catalysts, but investors should monitor execution risks in the competitive obesity drug market.

Open Text Corporation (OTEX) trades at $23.95, down 3.11% over the past day. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company shows strong profitability with a 73.74% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights Q4 2026 results with cloud revenue growth and strategic investments in AI.

The investment outlook is positive given attractive valuations like a P/E of 9.29 and a consensus price target of $29.33 implying significant upside. Key risks include execution of growth initiatives and competitive pressures in the software sector. Analyst sentiment is mixed but leans cautious with a majority hold rating.